Bryan Wahl, General Counsel at Tarsus Pharmaceuticals, Inc. (TARS), sold 16,712 shares at $16.31 ($273K) on 2023-11-30, disclosed to the SEC on 2023-12-01.
Open-market sale of $273k TARS by General Counsel. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $16.31 | 8,356 | $136K | 50.0% |
| 2 | $16.31 | 8,356 | $136K | 50.0% |
| Total | $16.31 avg | 16,712 | $273K | 100% |
| Filing → |
| TARS | SELL | 2024-03-19 | $271K | — | Filing → |
| TARS | SELL | 2023-03-23 | $14K | — | Filing → |
| TARS | SELL | 2023-03-21 | $9K | — | Filing → |